...
首页> 外文期刊>BJU international >Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged < 60 years: results from a multicentric European study
【24h】

Clinical performance of serum isoform [-2]proPSA (p2PSA), and its derivatives %p2PSA and the Prostate Health Index, in men aged < 60 years: results from a multicentric European study

机译:血清亚型[-2] proPSA(p2PSA)及其衍生物%p2PSA和前列腺健康指数在60岁以下男性中的临床表现:一项欧洲多中心研究的结果

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

ObjectivesTo test the hypothesis that [-2]proPSA (p2PSA) and its derivatives are more accurate than total prostate-specific antigen (tPSA), free prostate-specific antigen (fPSA) and fPSA as percentage of tPSA (%fPSA) in detecting prostate cancer (PCa) in men aged <60 years.
机译:目的为了检验以下假设:[-2] proPSA(p2PSA)及其衍生物比总前列腺特异性抗原(tPSA),游离前列腺特异性抗原(fPSA)和fPSA占tPSA百分比(%fPSA)的准确性更高<60岁的男性患有癌症(PCa)。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号